Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Microneedling is generally safe but can cause minor, temporary side effects and requires caution for some patients.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Human hair protein modifications could potentially indicate heart disease risk.

PRP injections are not proven effective for treating erectile dysfunction.

Scalp skin is a good option for skin grafts, healing well with proper care.

Taking oral contraceptives while on isotretinoin may increase the risk of high triglyceride and cholesterol levels.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Oral minoxidil may help with pediatric hair disorders but has notable side effects.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Lasers are effective for hair removal, skin rejuvenation, and acne treatment in dermatology.

MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.

Low-dose oral minoxidil is safe for treating children's hair disorders.

The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.

Tofacitinib is an effective and safe treatment for alopecia areata.

Most minoxidil products on Amazon don't provide safety or side effect information.

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Cochrane systematic reviews have better methodological quality than non-Cochrane ones, and improvements are needed for the latter.

Cochrane and non-Cochrane drug safety reviews report well in PRISMA but poorly in PRISMA harms, with non-Cochrane needing improvement.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Rubbing lotion or cream increases caffeine absorption through the skin but not rhododendrol.

Tripterygium wilfordii Hook F often causes side effects like stomach issues and skin reactions.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.